Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2018 Oct 3;13(4):479–487. doi: 10.1007/s11481-018-9813-6

Table 4.

Descriptive statistics on functional outcomes

Current use

Abstinent (n=63) Low use (n=24) Heavy use (n=24) Total (N=111)
Physical Health
    PROMIS Global Health-Physical, Mean (SD)*, ac, bc 48.3 (9.2) 50.9 (7.4) 42.2 (8.4) 47.4 (9.1)
    St. George’s Respiratory Questionnaire (SGRQ), Mean (SD) 24.1 (24.8) 24.4 (30.0) 35.0 (32.0) 26.0 (27.7)
    PROMIS Sleep Disturbance (PSD), Mean (SD)**, ac 50.5 (9.4) 54.0 (9.0) 58.6 (11.5) 52.8 (10.3)
    Simplified Nutritional Appetite Questionnaire (SNAQ), Mean
(SD)**, ac, bc 15.5 (2.8) 15.0 (2.8) 12.5 (3.7) 14.8 (3.2)
        High risk of weight loss within 6 months (<=14) (%)** 25.4 29.2 70.8 35.4
Mental Health
    Hospital Anxiety and Depression Scale (HADS)
        Anxiety, Mean (SD)**, ac 5.6 (4.3) 7.2 (3.8) 8.2 (4.7) 6.5 (4.4)
            Normal (%) 67.2 56.5 45.8 60.9
            Borderline abnormal (%) 16.4 21.7 16.7 17.3
            Abnormal (%) 16.4 21.7 37.5 21.8
        Depression, Mean (SD)**,ac 5.2 (4.4) 6.5 (3.6) 8.2 (4.3) 5.9 (5.6)
            Normal (%) 68.9 60.9 41.7 61.8
            Borderline abnormal (%) 16.4 17.4 33.3 20.0
            Abnormal (%) 14.8 21.7 25.0 18.2
    Patient Health Questionniare-9 (PHQ-9), Mean (SD)**, ac, bc 4.9 (5.0) 5.2 (3.7) 9.8 (7.2) 5.9 (5.6)
Cognition, Mean (SD)
    PROMIS Cognitive Function (PCS)**, ac 52.4 (9.4) 47.2 (8.2) 42.4 (12.0) 49.0 (10.5)
    PROMIS Cognitive Function Abilities (PCSA) 51.1 (10.5) 50.2 (10.2) 46.1 (9.2) 49.7 (10.2)

Group comparison based on Chi-square test for categorical variables or ANOVA test for continuous variables

*

P<0.05,

**

P<0.01

Pairwise comparison of mean scores based on the Tukey-Kramer method

a

= no use,

b

= low use,

c

= heavy use